[HTML][HTML] Assessment of In Vitro Cefiderocol Susceptibility and Comparators against an Epidemiologically Diverse Collection of Acinetobacter baumannii Clinical …
C Ballesté-Delpierre, Á Ramírez, L Muñoz… - Antibiotics, 2022 - mdpi.com
Cefiderocol is a catechol-substituted siderophore cephalosporin combining rapid
penetration into the periplasmic space with increased stability against β-lactamases. This …
penetration into the periplasmic space with increased stability against β-lactamases. This …
Activity of Cefiderocol Against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii Endemic to Medical Centers in New York City
A Iregui, Z Khan, D Landman, J Quale - Microbial Drug Resistance, 2020 - liebertpub.com
Therapeutic options for the treatment of infections owing to multidrug-resistant Gram-
negative pathogens are often limited. Cefiderocol is a novel siderophore cephalosporin with …
negative pathogens are often limited. Cefiderocol is a novel siderophore cephalosporin with …
Comparison of Agar Dilution to Broth Microdilution for Testing In Vitro Activity of Cefiderocol against Gram-Negative Bacilli
Cefiderocol (CFDC) is a siderophore cephalosporin with activity against Gram-negative
bacterial species that are resistant to carbapenems and other drugs. The MICs of CFDC …
bacterial species that are resistant to carbapenems and other drugs. The MICs of CFDC …
In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against Carbapenem-Nonsusceptible and Multidrug-Resistant Isolates of Gram-Negative Bacilli …
MA Hackel, M Tsuji, Y Yamano, R Echols… - Antimicrobial agents …, 2018 - Am Soc Microbiol
The in vitro activity of the investigational siderophore cephalosporin, cefiderocol (formerly S-
649266), was determined against a 2014–2016, 52-country, worldwide collection of clinical …
649266), was determined against a 2014–2016, 52-country, worldwide collection of clinical …
In Vitro Antibacterial Activity of Cefiderocol against Multidrug-Resistant Acinetobacter baumannii
JC Abdul-Mutakabbir, L Nguyen… - Antimicrobial agents …, 2021 - Am Soc Microbiol
Cefiderocol (CFDC), a novel siderophore cephalosporin, demonstrates strong activity
against multidrug-resistant (MDR) Acinetobacter baumannii. Limited studies have evaluated …
against multidrug-resistant (MDR) Acinetobacter baumannii. Limited studies have evaluated …
In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against a Recent Collection of Clinically Relevant Gram-Negative Bacilli from North America and …
MA Hackel, M Tsuji, Y Yamano, R Echols… - Antimicrobial agents …, 2017 - Am Soc Microbiol
ABSTRACT Cefiderocol (formerly S-649266) is an investigational siderophore
cephalosporin. Iron-depleted cation-adjusted Mueller-Hinton broth (ID-CAMHB) was …
cephalosporin. Iron-depleted cation-adjusted Mueller-Hinton broth (ID-CAMHB) was …
Cefiderocol antimicrobial susceptibility testing considerations: the Achilles' heel of the Trojan horse?
ABSTRACT Cefiderocol (formerly S-649266) is a novel siderophore-conjugated
cephalosporin with activity against a broad array of multidrug-resistant (MDR), aerobic Gram …
cephalosporin with activity against a broad array of multidrug-resistant (MDR), aerobic Gram …
[HTML][HTML] In Vitro Antimicrobial Activity of the Siderophore Cephalosporin Cefiderocol against Acinetobacter baumannii Strains Recovered from Clinical Samples
D Carcione, C Siracusa, A Sulejmani, R Migliavacca… - Antibiotics, 2021 - mdpi.com
Background: Cefiderocol is a siderophore cephalosporin that exhibits antimicrobial activity
against most multi-drug resistant Gram-negative bacteria, including Enterobacterales …
against most multi-drug resistant Gram-negative bacteria, including Enterobacterales …
[HTML][HTML] In vitro activity of cefiderocol, a siderophore cephalosporin, against Gram-negative bacilli isolated by clinical laboratories in North America and Europe in …
JA Karlowsky, MA Hackel, M Tsuji, Y Yamano… - International journal of …, 2019 - Elsevier
ABSTRACT Cefiderocol (S-649266) is a parenteral siderophore cephalosporin in phase III
of clinical development. In this study, we determined the in vitro susceptibility to cefiderocol …
of clinical development. In this study, we determined the in vitro susceptibility to cefiderocol …
Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals
ME Falagas, T Skalidis, KZ Vardakas… - Journal of …, 2017 - academic.oup.com
Background: Cefiderocol (S-649266), a siderophore cephalosporin, utilizes a novel
mechanism of entry into the periplasmic space of Gram-negative bacteria and is broadly …
mechanism of entry into the periplasmic space of Gram-negative bacteria and is broadly …